LBD: a manually curated database of experimentally validated lymphoma biomarkers (original) (raw)
General Biomarker Recommendations for Lymphoma
Lale Kostakoglu
Journal of the National Cancer Institute, 2016
View PDFchevron_right
The current lymphoma classification: new concepts and practical applications triumphs and woes
Irfan Maghfoor
Annals of Saudi medicine
View PDFchevron_right
Biomarkers and Prognosis in Malignant Lymphomas
M. Dreyling
Clinical Lymphoma and Myeloma, 2009
View PDFchevron_right
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
Poonam Nagpal
Oncotarget
View PDFchevron_right
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
Stephen Schuster
Annals of Oncology, 2017
View PDFchevron_right
Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B‐Cell Lymphoma
Naohiko Koshikawa
PROTEOMICS – Clinical Applications, 2019
View PDFchevron_right
New approaches to lymphoma diagnosis
Laura Pasqualucci
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2001
View PDFchevron_right
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
Randy Gascoyne
Blood cancer journal, 2018
View PDFchevron_right
Development of a Malignancy-Associated Proteomic Signature for Diffuse Large B-Cell Lymphoma
Douglas Faller
The American Journal of Pathology, 2009
View PDFchevron_right
Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas
Delphine Rolland
Proceedings of the National Academy of Sciences of the United States of America, 2017
View PDFchevron_right
Taming the Heterogeneity of Aggressive Lymphomas for Precision Therapy
Louis Staudt, Arthur Shaffer
Annual Review of Cancer Biology, 2019
View PDFchevron_right
Current Concepts in Lymphoma Biology: Effect on Management and Outcome
Irfan Maghfoor
View PDFchevron_right
Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications--A Study From the Lunenburg Lymphoma Biomarker Consortium
Daphne Jong
Journal of Clinical Oncology, 2007
View PDFchevron_right
Biomarkers of diffuse large B-cell lymphoma: impact on diagnosis, treatment, and prognosis
John Gribben
Current Biomarker Findings, 2013
View PDFchevron_right
Reproducibility of Gene Expression Signatures in Diffuse Large B-Cell Lymphoma
Arjan Diepstra
Cancers, 2022
View PDFchevron_right
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
Thomas Habermann
International Journal of Epidemiology, 2017
View PDFchevron_right
Personalized Treatment of Lymphoma: Promise and Reality
Koen van Besien
Seminars in Oncology, 2011
View PDFchevron_right
Discovery and Identification of Potential Biomarkers in a Prospective Study of Chronic Lymphoid Malignancies Using SELDI-TOF−MS
Laurent Mauvieux
Journal of Proteome Research, 2006
View PDFchevron_right
Immunohistochemical prognostic indicators of lymphoma tumors
Yousef Mosameh
African Journal of Biotechnology, 2009
View PDFchevron_right
Diagnosis and classification of lymphoma: Impact of technical advances
Paola Angelina Faundez jofre
View PDFchevron_right
Concordance Between Immunohistochemistry and Gene Expression Profiling Subtyping for Diffuse Large B-Cell Lymphoma in the Phase 3 Phoenix Trial
Christina Loefgren
Hematological Oncology, 2019
View PDFchevron_right
Molecular Profiling of Aggressive Lymphomas
Stefano Pileri
Advances in Hematology, 2012
View PDFchevron_right
Evaluation of Some Biochemical Markers as Prognostic Factors in Malignant Lymphomas
Laila Eissa
2006
View PDFchevron_right
Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin’s Lymphoma Study Group
carlos grande
Journal of Clinical Oncology, 2004
View PDFchevron_right
Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment
Tasleem Arif
PLOS ONE, 2016
View PDFchevron_right
Putting the clinical and biological heterogeneity of non-hodgkin lymphoma into context
Owen O'Connor
Clinical cancer research : an official journal of the American Association for Cancer Research, 2014
View PDFchevron_right
Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib-Rituximab Versus Rituximab
Joanna Romejko-Jarosinska
Clinical Cancer Research, 2013
View PDFchevron_right
Advances in Classical Hodgkin Lymphoma Biology: New Prognostic Factors and Outcome Prediction Using Gene Expression Signatures
Margarita Sánchez-beato
Hodgkin's Lymphoma, 2012
View PDFchevron_right
Reliable subtype classification of diffuse large B-Cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assay
Randy Gascoyne
Haematologica, 2017
View PDFchevron_right
Abstract 766: Refractory and relapsed predictive biomarkers in Hodgkin lymphoma and potential directed-therapy targets
Stella Ranuncolo
Cancer Research, 2018
View PDFchevron_right
Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia
Henrik Frederiksen
Cancers, 2021
View PDFchevron_right
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma
Stefano Pileri
Haematologica, 2020
View PDFchevron_right
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
Annuska M Glas, Daphne Jong
Blood, 2005
View PDFchevron_right
Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
Stefano Pileri
Cells, 2021
View PDFchevron_right